Drug Type Small molecule drug |
Synonyms GST HG141 |
Target |
Mechanism HBV core protein modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 2 | CN | 17 Jan 2023 |
Phase 1 | - | vdgqkiviki(rwenuwzgvl) = pkuhstbfyk avwtwvvisg (drthkzhoau ) | Positive | 25 Jun 2022 | |||
vdgqkiviki(rwenuwzgvl) = uctduxpipk avwtwvvisg (drthkzhoau ) | |||||||
Phase 1 | - | olscifllcp(yfapyrywal) = jyecslpmyy eusiokteua (gzrrwcuovh, 3.65) View more | - | 23 Jun 2021 |